APA (7th ed.) Citation

AM, S., A, M., TT, H., A, A., MF, B., & R, B. (2022). Atogepant - an orally-administered CGRP antagonist - attenuates activation of meningeal nociceptors by CSD. Cephalalgia : an international journal of headache, 42(9), 933. https://doi.org/10.1177/03331024221083544

Chicago Style (17th ed.) Citation

AM, Strassman, Melo-Carrillo A, Houle TT, Adams A, Brin MF, and Burstein R. "Atogepant - an Orally-administered CGRP Antagonist - Attenuates Activation of Meningeal Nociceptors by CSD." Cephalalgia : An International Journal of Headache 42, no. 9 (2022): 933. https://doi.org/10.1177/03331024221083544.

MLA (9th ed.) Citation

AM, Strassman, et al. "Atogepant - an Orally-administered CGRP Antagonist - Attenuates Activation of Meningeal Nociceptors by CSD." Cephalalgia : An International Journal of Headache, vol. 42, no. 9, 2022, p. 933, https://doi.org/10.1177/03331024221083544.